Neural stem cells (NSCs), which are responsible for continuous neurogenesis during the adult stage, are present in human adults. The typical neurogenic regions are the hippocampus and the subventricular zone; recent studies have revealed that NSCs also exist in the olfactory bulb. Olfactory bulb-derived neural stem cells (OB NSCs) have the potential to be used in therapeutic applications and can be easily harvested without harm to the patient. Through the combined influence of extrinsic cues and innate programming, adult neurogenesis is a finely regulated process occurring in a specialized cellular environment, a niche. Understanding the regulatory mechanisms of adult NSCs and their cellular niche is not only important to understand the physiological roles of neurogenesis in adulthood, but also to provide the knowledge necessary for developing new therapeutic applications using adult NSCs in other organs with similar regulatory environments. Diabetes is a devastating disease affecting more than 200 million people worldwide. Numerous diabetic patients suffer increased symptom severity after the onset, involving complications such as retinopathy and nephropathy. Therefore, the development of treatments for fundamental diabetes is important. The utilization of autologous cells from patients with diabetes may address challenges regarding the compatibility of donor tissues as well as provide the means to naturally and safely restore function, reducing future risks while also providing a long-term cure. Here, we review recent findings regarding the use of adult OB NSCs as a potential diabetes cure, and discuss the potential of OB NSC-based pharmaceutical applications for neuronal diseases and mental disorders.
Introduction
Neural stem cells (NSCs) are defined as undifferentiated cells that can self-renew as well as give rise to the differentiated cell lines that constitute the central nervous system (CNS): neurons, astrocytes, and oligodendrocytes (Gage et al., 1995; Gage, 2000; Okano, 2002; Ma et al., 2010 ; Figure 1 ). Neurons are the functional components of the CNS and are responsible for information processing and transmission; astrocytes and oligodendrocytes are known as 'glia' and play supporting roles that are essential for the proper neuronal function (Abematsu et al., 2006; Basak and Taylor, 2009) . Active adult neurogenesis is restricted, under physiological conditions, to two specific 'neurogenic' brain regions, the subgranular zone (SGZ) in the dentate gyrus of the hippocampus and the subventricular zone of the lateral ventricles (Gage, 2000; Kempermann and Gage, 2000) . The sources of the neurogenic adult NSCs are present in these regions.
The two types of progenitor cells are present in the SGZ and are distinguished by their distinct morphologies in the hippocampus. Type 1 progenitor cells express nestin, glial fibrillary acidic protein (GFAP), and the Sry-related high-mobility group (HMG)-box transcription factor Sox2 (Fukuda et al., 2003 , Garcia et al., 2004 . The cells have a radial process spanning the entire granule cell layer, and ramify into the inner molecular layer. Sox2-positive type 2 NSCs have only short processes and do not express GFAP. These type 2 NSCs, present in the dentate gyrus region of the hippocampus, can self-renew, and a single Sox2-positive NSC can give rise to a neuron or an astrocyte in vivo (Suh et al., 2007) . The transcription factor Sox2 is important for maintaining the 'multipotency' not only of adult NSCs but also of embryonic stem cells (ESCs; Zappone et al., 2000; D'Amour and Gage, 2003; Ferri et al., 2004) .
Adult NSCs retaining multipotency express Sox2
Stem cells, or undifferentiated cells, in vertebrates (Asashima et al., 1990 (Asashima et al., , 2008 (Asashima et al., , 2009 Okabayashi and Asashima, 2003; Kurisaki et al., 2010) are broadly classified into two types: ESCs, which are present during the embryonic stage, and adult stem cells, which are present in the tissues of adults. The HMG-box transcription factor Sox2 is expressed in ESCs and in the most uncommitted cells in the developing CNS (Nishimoto et al., 1999; Ferri et al., 2004) . The expression of the Sox2 transcription factor helps to maintain stem cell populations in a multipotent state during embryonic development, and its ablation causes early embryonic lethality (Avilion et al., 2003) . An enforced expression of four transcription factors (Oct4, Klf4, c-Myc, and Sox2) in differentiated somatic cells can induce them to adopt a phenotype similar to ESCs (induced pluripotent stem cells, iPSCs) (Takahashi and Yamanaka, 2006; Baker, 2007) . Since human iPSCs share many characteristics with human ESCs, reprogrammed iPSCs offer opportunities for the creation of autologous cellular therapies (Gekas and Graf, 2010; Weir et al., 2011; Maury et al., 2012) .
Sox2 is expressed by endogenous NSCs and by the vast majority of dividing precursors in the neurogenic regions of the adult brain to maintain their proliferation. Ferri et al. (2004) showed that Sox2 is expressed in proliferating precursor cells in vivo and in adult brain-derived NSC cultures in vitro. Similarly, a Sox2 deficiency was shown to cause neurodegeneration and impaired neurogenesis in adults. In the hippocampus, Sox2-expressing NSCs were shown to give rise to neurons and glia as well as NSCs that retain Sox2 expression (self-renewal). This was demonstrated at the single-cell level by using the lentivirus-and retrovirus-mediated fate-tracing studies (Suh et al., 2007) .
The olfactory bulb, the part of the brain that receives the axonal input from the sensory neurons in the nose, also contains NSCs. The identification and isolation of NSCs from the adult human brain has been seen as an exciting discovery, raising hopes for their use in the treatment of neurodegenerative diseases. Neurogenesis in the olfactory bulb is tightly regulated such that the number of mature sensory neurons is maintained at a constant surface density (Mackay-Sim et al., 1988; Kuhn et al., 2005) . The signals that support populations of proliferating stem cells, or precursor cells, influence the final numbers of neurons derived from these populations. Similarly, a variety of signaling proteins are required to maintain NSCs in their undifferentiated state in vitro. NSCs are isolated and cultured in the presence of a defined concentration of the basic fibroblast growth factor (FGF) and/or epidermal growth factor (EGF) under serum-free conditions (Johe et al., 1996) . Insulin-like growth factor-1 (IGF-1) and IGF-2 are secreted proteins that have been demonstrated to promote neuronal survival by preventing their natural cell death (De Pablo and de la Rosa, 1995) . IGF-1 is also required for an FGF-2-mediated promotion on the proliferation and survival of neurons in vitro (Drago et al., 1991) . As mentioned previously, multipotent NSCs can be derived from the olfactory bulb (Pagano et al., 2000; Dictus et al., 2007; Kuwabara et al., 2011) , and FGF-2 is required to maintain the NSCs in an undifferentiated and proliferative state. The maintenance of their undifferentiated state is mediated by the promotion of the expression of genes such as Sox2. As may be inferred from this description, the maintenance of multipotent stem cells in vitro requires complex regulation by a number of signaling mechanisms (Figure 1 ).
Insulin and neurogenesis
Insulin appears to have a necessary role in brain function (Wickelgren, 1998) , including the hippocampal energy metabolism (Hoyer et al., 1996; Biessels et al., 1996; Ye et al., 2011) and the facilitation of learning and memory (Craft et al., 1996; Biessels et al., 1996; Ye et al., 2011) . Energy metabolism is an essential regulator of the function of adult NSCs (Rafalski and Brunet, 2011) . Among the various signaling molecules, insulin, IGF-1, and IGF-2 provide instructive signals for regulating the fate of adult NSCs (Hsieh et al., 2004 ; Figure 1 ). Insulin and IGF-1 receptors are widely expressed in the brain (Aberg et al., 2003; Hsieh et al., 2004) , and insulin and IGFs have been demonstrated to have mitogenic effects on NSCs (Arsenijevic et al., 2001) . IGF-1 can stimulate neurogenesis in the dentate gyrus (Aberg et al., 2000) , as well as increase the proliferation and neuronal differentiation of EGF-responsive multipotent NSCs derived from E14 mouse striatum (Arsenijevic et al., 2001) . The overexpression of IGF-1 in transgenic mice results in an increased brain size and myelin content (Carson et al., 1993) . Conversely, IGF-1 knockout mice have smaller brains and CNS hypomyelination (Carson et al., 1993; Beck et al., 1995) .
It is well known that diabetes impairs hippocampal learning and memory (Stranahan et al., 2008) . Diabetes mellitus (Terauchi and Kadowaki, 2002; Kadowaki et al., 2003; Kadowaki, 2011; Naito et al., 2011) is associated with moderate impairments in cognitive function and patients present a high risk of affective disorders, dementia, and Alzheimer's disease (Ott et al., 1999; Brismar et al., 2007) . The pathogenesis of these deficits is multifactorial, probably involving other microvascular dysfunction and oxidative stress, and the mechanism has not been fully elucidated. Independent studies, using diabetes animal models, indicated that diabetes is associated with reduced neural progenitor proliferation and neurogenesis (Stranahan et al., 2008; Guo et al., 2010) . The inability to produce insulin at efficient levels causes detrimental effects on adult neurogenesis and synaptic neuronal plasticity (Stranahan et al., 2008) . Unregulated glucose levels (hyperglycemia) are detrimental to the neurogenesis originating from adult NSCs, which, in turn, may play a role in the cognitive decline observed in humans with diabetes (Craft and Christen, 2010) . 
Insulin expression in neurons
In Drosophila, insulin is produced by neurons within the brain (Brogiolo et al., 2001; Rulifson et al., 2002) . Clusters of these insulin-producing cells in the brains of flies and the vertebrate pancreatic islet b cells are considered the functional analogs that evolved from a common ancestral insulin-producing neuron (Rulifson et al., 2002) . There are considerable similarities between the genes expressed in the developing brain and pancreas in mammals (Habener et al., 2005; Hori et al., 2005) . Despite their separate developmental origins, the gene expression programs for developing neurons and b cells are remarkably similar (Habener et al., 2005) .
In the first stage, during the neuronal differentiation from adult NSCs, early committed neuronal progenitors transiently express BETA2/neurogenic differentiation protein (NeuroD). NeuroD, a member of the basic helix-loop-helix family of transcription factors, plays an essential role in both the pancreas and the brain (Naya et al., 1997; Miyata et al., 1999; Liu et al., 2000) . A NeuroD deficiency in mice causes severe diabetes and perinatal lethality because NeuroD is required for insulin gene expression (Naya et al., 1997) . The adenovirus-mediated introduction of NeuroD can also induce ectopic insulin expression in the liver (Kojima et al., 2003) . Noguchi et al. (2005) demonstrated that the NeuroD protein permeates several cells and enhances the insulin promoter activity. Protein therapy with NeuroD proteins has been shown to alleviate the symptoms of diabetes mellitus in vivo via enhancing insulin expression (Huang et al., 2007) .
A NeuroD deficiency during hippocampal development leads to the complete loss of the dentate gyrus (where neurogenesis occurs and NSCs reside) formation in mice (Miyata et al., 1999; Liu et al., 2000) . NeuroD1-positive cells are clearly detected in early-stage neurons in the SGZ region of the dentate gyrus and never co-localize with Sox2-expressing NSCs (Kuwabara et al., 2009 ). An inducible adult NSC-specific deletion of NeuroD in transgenic mice results in substantially fewer newly differentiated neurons in the hippocampus and olfactory bulb (Gao et al., 2009) , suggesting that NeuroD is a critical regulator of adult neurogenesis. Consistent with the proneural expression of NeuroD during adult neurogenesis (Gao et al., 2009; Kuwabara et al., 2009) , we recently demonstrated that insulin was expressed in neurons in the hippocampus and olfactory bulb, and that NeuroD activates insulin expression (Supplementary Figure S1) .
Insulin expression levels are comparatively lower in neurons than in pancreatic islets, suggesting that other enhancer(s) are present in pancreatic endocrine lineages that function to help increase insulin expression (Kuwabara et al., 2011) .
Niches supporting insulin expression via NeuroD in adult NSCs
NeuroD1 has been shown to be dependent on the canonical Wnt/b-catenin activation and the removal of Sox2 repression from the NeuroD promoter in a sequence-specific manner during adult neurogenesis (Kuwabara et al., 2009) . Further, Wnt/b-catenin signaling is necessary to trigger the neuronal differentiation of adult NSCs (Lie et al., 2005) . The cells comprising the bottom layer of the hippocampal granule neuron layer are called astrocytes and they produce Wnt3/Wnt3a and, therefore, play an important, paracrine-like role in controlling adult neurogenesis (Song et al., 2002; Okamoto et al., 2011) .
As people age, the number of adult NSCs decreases significantly, as does their ability to generate diverse neuronal populations (Lee et al., 2012) . The frequency of neurogenesis varies significantly with the environment in which an individual lives, with stress and disease having a negative impact on the process. In neurodegenerative diseases and mental disorders, such as Alzheimer's disease, dementia, and depression, adult neurogenesis declines more significantly. This indicates that adult neurogenesis is regulated by a molecular mechanism that can vary as a result of both external stimuli and the biological environment in which an individual lives.
In diabetes, deficits in insulin secretion influence the pancreatic endocrine system and the neuronal function within the brain. Both type 1 and type 2 diabetes are characterized by marked reductions in Wnt3 expression in the pancreas and the brain (Kuwabara et al., 2011) . A family of IGF-binding proteins (Firth and Baxter, 2002) modulates the bioactivity of IGF and impairs Wnt/b-catenin signaling (Zhu et al., 2008) ; the most potent Wnt inhibitor is the insulin-like growth factor-binding protein-4 (IGFBP-4; Zhu et al., 2008) . In diabetes, IGFBP-4 is upregulated in both the adult brain and the pancreas, suggesting that the balance between the stimulatory actions of Wnt3 and the inhibitory actions of IGFBP-4 is regulated by the diabetes status. Interestingly, Wnt3 expression is detected in pancreatic a cells together with the GFAP astrocytic marker, again indicating the similarity of gene regulation between the CNS and the pancreas. Physiologically induced changes (such as those during diabetes) in Wnt3 and IGFBP-4 expression might reflect the changes occurring in specific niches in both the pancreas and the adult CNS.
Autologous NSC therapy for diabetes
For autologous cells to have a potential application in regenerative medicine, the cells must be collected from a suitable source. An endoscopic collection of multipotent NSCs from the olfactory bulb is obviously preferable to the surgical collection of intracerebellar NSCs through a difficult and risky surgery. Adult NSCs collected from both the hippocampus and the olfactory bulbs of diabetic rats were transplanted back into diabetic rats after increasing the insulin expression capability of the NSCs by ex vivo culture with the recombinant Wnt3 protein and antibody against IGFBP-4. Grafted cells started to express the several key characteristics of pancreatic b cells (including Ptf1a and MafA), suggesting that grafted NSCs respond to the niche signals in the pancreas and unleash their intrinsic ability to express the critical regulators of pancreatic insulin production. Grafted NSCs survived over a prolonged period and the transplant-derived neurons continued to produce insulin even 10 weeks after their transplantation; the insulin was bioactive, resulting in reduced blood glucose levels (Kuwabara et al., 2011) . Removing the grafted cell sheets from the recipient animals 15-19 weeks after transplantation led to a rise in their blood glucose levels again, indicating that transplanting NSCs into the pancreas could be an effective treatment for diabetes.
The transplantation strategy (Figure 2) does not require the introduction of any inductive genes and confirms that there is a strong functional similarity between adult neurons and endocrine b cells. It will be essential to validate these results with the available human NSC lines as well as patient-derived olfactory bulb NSCs. Adult NSCs possess the intrinsic ability to generate insulin-producing cells via Wnt/b-catenin signaling, and various studies have emphasized the presence of conserved Wnt signaling networks and their niches among developmentally distinct tissues. The use of adult NSCs for treating diabetes is potentially advantageous because donors are not required, the introduction of inductive genes is not necessary, and extracellular and endogenous regulation suitably resembles that employed by adult islet endocrine cell lineages. The basic strategy outlined should be useful for the preliminary treatment of diabetes using the patient's own NSCs before the disease progresses.
Modeling pathogenesis using various types of stem cells from patients
Adult neurogenesis is also modulated in neurological diseases and disorders like Alzheimer's disease, depression, epilepsy, and Huntington disease and Parkinson disease. Although it is relatively easy to extract and to analyze the adult stem cells from some organs and tissues, including the liver, skin, fat, and bone marrow, in a living individual, it is extremely difficult to obtain NSCs/progenitors or biopsy material from the hippocampus. It is also possible to perform research on basic molecular mechanisms by combining adult NSC culture systems with animal experimentation. However, it is virtually impossible to analyze living adult hippocampal NSCs from patients with psychiatric/mental disorders, or to analyze the processes, for example, by which differentiated neurons or glial cells function and the intercellular responses to changes during progression to the disease state.
To overcome these issues, research using iPSCs from patients with a variety of neuropsychiatric/mental disorders were performed. Established iPSCs from patients were differentiated into neurons and compared with neurons derived from iPSCs established from healthy human subjects. Whether or not specific causative genes, previously identified in animal-based studies, actually contribute to functional abnormalities in iPS neurons derived from diseased human tissue has been investigated and confirmed in several diseases, including spinal muscular atrophy, familial dysautonomia, Rett syndrome, and schizophrenia (SZ) (Ebert et al., 2009; Lee et al., 2009; Marchetto et al., 2010) . When neurons were transformed from cultured patientspecific iPSCs, the iPS-derived neurons made fewer connections, or synapses, with other neurons from people without mental disorders. A mitigating/repairing effect on patient iPS-derived neurons was actually seen when clinical reagents for SZ patients were added in the culture dish (Brennand et al., 2011) . iPS cell lines from multiple patients and controls will need to be compared for their responses in order to investigate the variability due to the individual donor and the disease status.
On the other hand, differences between cells derived from patients with mental disorders and those from healthy people could reflect changes brought about by the process of creating iPSCs with the four exogenous gene products (Oct4, Klf4, c-Myc, and Sox2) and not the disease itself. Since human iPSCs share many characteristics with human ESCs, differentiated neurons derived from patient iPSCs could also reflect regulation during the embryonic stage rather than the adult stage. The regulation of NSCs during the embryonic stage is different from that occurring during the adult stage with regard to both the extracellular signals and the intracellular genetic programs. The development of the CNS begins as a sheet of cells made up of primary progenitors known as neuroepithelial cells (Merkle and Alvarez-Buylla, 2006) . At the onset of CNS formation, neuroepithelial cells are thought to be replaced by different NSCs. The neuroepithelial cells gradually transform to radial glial cells by changing their morphology and producing different progeny (Wen et al., 2009) .
Microarray analyses and quantitative reverse transcriptionpolymerase chain reaction analyses of NSCs derived from the adult hippocampus and the olfactory bulb have revealed that adult NSCs from the olfactory bulb share many characteristics with NSCs from the adult hippocampus. Both olfactory bulb and hippocampal NSCs responded similarly in a dose-dependent manner to exposure to exogenous ligands and chemical reagents (Kuwabara et al., 2011) . Results such as these open up the possibility of screening drugs using adult NSCs derived from the patient's own olfactory bulb (Figure 3) .
If such experimental systems are used, they may be applied to the drug discovery screening that involves cells that are functionally similar to those that comprise tissues that are difficult to access. Beyond that, it may be possible to provide 'made-toorder' disease treatments (personalized treatments) adapted to individual differences (Figure 3) . Figure 2 Schematic representation of regenerative therapy for diabetes using autologous adult NSCs. Adult NSCs are extracted from the olfactory bulb surgically using an endoscope. Because NSCs in diabetic animals had been found to contain higher IGFBP-4 (the Wnt inhibitor) and lower levels of Wnt3/Wnt3a (activators for insulin production via the NeuroD activation) than that in wild-type animals (Kuwabara et al., 2011) , treating the cultured NSCs with Wnt3/Wnt3a ligands and anti-IGFBP-4 (neutralizing antibody against the IGFBP-4 protein) rescues insulin expression during ex vivo culture on the collagen sheets.
Conclusions
Various cell-based approaches have been explored for diabetes treatment: (i) differentiation to the b cell lineage from ESCs and/ or iPSCs (Kajiyama et al., 2010; Moriya et al., 2000; Lumelsky et al., 2001; Nakanishi et al., 2007; Tateishi et al., 2008) , (ii) a direct conversion of differentiated cells into b cells (Zhou et al., 2008; Thorel et al., 2010) , and (iii) transdifferentiation of adult progenitor cells (Seaberg et al., 2004) . With a focus on tissue and organ regeneration, a method that 'replenishes' the stem cells present in tissues appears to be the shortest route to restore lost function. Cells derived from iPSCs have the advantage of higher growth rates and are easier to prepare in large quantities in comparison with the process of establishing and culturing the adult stem cells present in small numbers in adult tissues. However, similar to the ESC-derived regenerative medicine research field, iPSCs retain many ESC-like properties. Without conditioning these cells to the 'adult' environment, they may introduce unknown risks of abnormal growth or carcinogenesis in the future. In terms of stem cell regenerative medicine, it is important to activate the adult stem cells present in the patient's body safely and in a way closer to what occurs naturally. Thus, there appears to be enormous potential for the use of NSCs, derived from tissues that are comparatively easy to harvest, in both regenerative medicine and in pharmaceutical testing.
Supplementary material
Supplementary material is available at Journal of Molecular Cell Biology online. 
